Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Oka

Showing results (451-460 of 465) with videos related to

Pageof 47
Sort By:
AIDS Research and Human Retroviruses|March 15, 2000
Interleukin 18 and interleukin 1beta production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacsL He, H Terunuma, H Hanabusa, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Japanese Journal of Infectious Diseases|April 28, 2001
Evaluation of the AMPLICOR CMV, COBAS AMPLICOR CMV monitor and antigenemia assay for cytomegalovirus diseaseT Masaoka, A Hiraoka, K Ohta, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA--II. Modification of pyrrolidine ring at P1' prolineT Komai, S Higashida, M Sakurai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2013
Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patientsJ-H Lee, A Hachiya, S-K Shin, et al.
Japanese Circulation Journal|October 10, 1998
Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: a survey of primary care physiciansA Sakurai, S Oka, J Sekine, et al.
Leukemia|June 29, 2016
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph<sup>+</sup> leukemia patients treated with dasatinibK Ishiyama, T Kitawaki, N Sugimoto, et al.
HIV Medicine|November 5, 2020
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-PacificJ Ross, A Jiamsakul, N Kumarasamy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patientsA Vasilescu, Y Terashima, M Enomoto, et al.
Amino Acids|June 16, 2018
Selective modification of fluciclovine (<sup>18</sup>F) transport in prostate carcinoma xenograftsF I Tade, W G Wiles, G Lu, et al.
Pageof 47

Showing results (451-460 of 465) with videos related to

Sort By:
Pageof 47
AIDS Research and Human Retroviruses|March 15, 2000
Interleukin 18 and interleukin 1beta production is decreased in HIV type 1-seropositive hemophiliacs but not in HIV type 1-seropositive nonhemophiliacsL He, H Terunuma, H Hanabusa, et al.
Biological & Pharmaceutical Bulletin|February 1, 1997
In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acidT Komai, R Yagi, H Suzuki-Sunagawa, et al.
Japanese Journal of Infectious Diseases|April 28, 2001
Evaluation of the AMPLICOR CMV, COBAS AMPLICOR CMV monitor and antigenemia assay for cytomegalovirus diseaseT Masaoka, A Hiraoka, K Ohta, et al.
Bioorganic & Medicinal Chemistry|August 1, 1996
Structure-activity relationships of HIV-1 PR inhibitors containing AHPBA--II. Modification of pyrrolidine ring at P1' prolineT Komai, S Higashida, M Sakurai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2013
Restriction fragment mass polymorphism (RFMP) analysis based on MALDI-TOF mass spectrometry for detecting antiretroviral resistance in HIV-1 infected patientsJ-H Lee, A Hachiya, S-K Shin, et al.
Japanese Circulation Journal|October 10, 1998
Changes of ischemic heart disease in Utsunomiya, Japan, over 10 years: a survey of primary care physiciansA Sakurai, S Oka, J Sekine, et al.
Leukemia|June 29, 2016
Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph<sup>+</sup> leukemia patients treated with dasatinibK Ishiyama, T Kitawaki, N Sugimoto, et al.
HIV Medicine|November 5, 2020
Virological failure and HIV drug resistance among adults living with HIV on second-line antiretroviral therapy in the Asia-PacificJ Ross, A Jiamsakul, N Kumarasamy, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patientsA Vasilescu, Y Terashima, M Enomoto, et al.
Amino Acids|June 16, 2018
Selective modification of fluciclovine (<sup>18</sup>F) transport in prostate carcinoma xenograftsF I Tade, W G Wiles, G Lu, et al.
Pageof 47